The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast
Restricted accessResearch articleFirst published online July, 2022
The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast
The value of combined dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and apparent diffusion coefficient (ADC) histogram analysis for the diagnosis of breast cancer has not been evaluated in previous studies.
Purpose
To investigate the diagnostic value of DCE-MRI combined with ADC in benign and malignant breast lesions.
Material and Methods
The clinicopathological imaging data included 168 patients (177 lesions) with breast lesions who underwent convention breast MRI, DCE-MRI, and diffusion-weighted imaging (DWI); they were divided into the benign lesion group (n = 39) and malignant lesion group (n = 129) based on pathology.
Results
Using the type III outflow curve as a diagnostic criterion for malignant breast lesions, the diagnostic sensitivity was 76.9%, the specificity was 80%, the correct rate was 72.2%, and its area under the curve (AUC) was 0.823. Using an enhancement ratio > 100% as a diagnostic criterion for malignant breast lesions, the sensitivity was 61.5%, specificity was 80%, and AUC was 0.723. Using > 3 ipsilateral vessels as a diagnostic criterion for malignant lesions in the breast resulted in a diagnostic sensitivity of 81.6%, a specificity of 80.8%, and an AUC of 0.805.
Conclusion
The type of time intensity curve DCE-MRI, the early enhancement rate in the first phase, the number of ipsilateral vessels, and the ADC full volume histogram of the blood supply score and DWI are valuable in the diagnosis of benign and malignant breast lesions.
MoyLEliasKPatelV, et al. Is breast MRI helpful in the evaluation of inconclusive mammographic findings?AJR Am J Roentgenol2009;
193:986–993.
2.
PinkerKHelbichTHMorrisEA.The potential of multiparametric MRI of the breast. Br J Radiol2017;
90: 20160715.
3.
AllarakhaAGaoYJiangH, et al. Prediction and prognosis of biologically aggressive breast cancers by the combination of DWI/DCE-MRI and immunohistochemical tumor markers. Discov Med2019;
27:7–15.
4.
BramanNMEtesamiMPrasannaP, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res2017;
19:57.
5.
PartridgeSCNissanNRahbarH, et al. Diffusion-weighted breast MRI: Clinical applications and emerging techniques. J Magn Reson Imaging2017;
45:337–355.
6.
BaltzerPMannRMIimaM, et al. Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol2020;
30: 1436–1450.
7.
CipollaVGuerrieriDBonitoG, et al. Effects of contrast-enhancement on diffusion weighted imaging and apparent diffusion coefficient measurements in 3-T magnetic resonance imaging of breast lesions. Acta Radiol2018;
59:902–908.
8.
AhnSJParkMBangS, et al. Apparent diffusion coefficient histogram in breast cancer brain metastases may predict their biological subtype and progression. Sci Rep2018;
8:9947.
9.
HorvatJVIyerAMorrisEA, et al. Histogram analysis and visual heterogeneity of diffusion-weighted imaging with apparent diffusion coefficient mapping in the prediction of molecular subtypes of invasive breast cancers. Contrast Media Mol Imaging2019;
2019:2972189.
10.
NewittDCAmouzandehGPartridgeSC, et al. Repeatability and reproducibility of ADC histogram metrics from the ACRIN 6698 Breast Cancer Therapy Response Trial. Tomography2020;
6:177–185.
11.
JinYZhangYChengJ, et al. The role of histogram analysis in diffusion-weighted imaging in the differential diagnosis of benign and malignant breast lesions. BMC Med Inform Decis Mak2020;
20:239.
12.
XuFLiangYGuoY, et al. Diagnostic performance of whole-lesion apparent diffusion coefficient histogram analysis metrics for differentiating benign and malignant breast lesions: a systematic review and diagnostic meta-analysis. Acta Radiol2020;
61:1165–1175.
13.
LiuHZongMWeiH, et al. Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps. Clin Radiol2018;
73:460–466.
14.
TajimaYKurokiTTsutsumiR, et al. Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol2007;
13:858–865.
15.
SardanelliFIozzelliAFaustoA, et al. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology2005;
235:791–797.
16.
PartridgeSCStoneKMStrigelRM, et al. Breast DCE-MRI: influence of postcontrast timing on automated lesion kinetics assessments and discrimination of benign and malignant lesions. Acad Radiol2014;
21:1195–1203.
17.
FanWXChenXFChengFY, et al. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China. Medicine2018;
97:e9666.
18.
WeidnerNSempleJPWelchWR, et al. Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med1991;
324:1–8.
19.
SunCLiJWangB, et al. Tumor angiogenesis and bone metastasis - Correlation in invasive breast carcinoma. J Immunol Methods2018;
452:46–52.
20.
WangLLLinJPengLV.Non-small Cell Lung Cancer: Correlation between Parameters from IVIM, DCE-MRI and Immunohistochemistry Indices MVD, EGFR and Ki67. Chinese Journal of CT and MRI 2017; 15: 60–63.
21.
JunASAnCSSubKW, et al. Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model. Korean J Radiol2011;
12:722–730.
22.
JacobsMAWolffACMacuraKJ, et al. Multiparametric and multimodality functional radiological imaging for breast cancer diagnosis and early treatment response assessment.J Natl Cancer Inst Monogr2015;
2015:40–46.
23.
GombosECJagadeesanJRichmanDM, et al. Magnetic resonance imaging-guided breast interventions: role in biopsy targeting and lumpectomies. Magn Reson Imaging Clin N Am2015;
23:547–561.
24.
MenezesGLKnuttelFMStehouwerBL, et al. Magnetic resonance imaging in breast cancer: A literature review and future perspectives. World J Clin Oncol2014;
5:61–70.
25.
MahfouzAESherifHSaadA, et al. Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity?Eur Radiol2001;
11:965–969.
26.
CarrieroADi CredicoAMansourM, et al. Maximum intensity projection analysis in magnetic resonance of the breast. J Exp Clin Cancer Res2002;
21:77–81.
27.
SchmitzACPetersNHVeldhuisWB, et al. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps. Eur Radiol2008;
18:355–364.
28.
MengJZhuLZhuL, et al. Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy. Radiat Oncol2016;
11:141.
29.
UmanodanTFukukuraYKumagaeY, et al. ADC histogram analysis for adrenal tumor histogram analysis of apparent diffusion coefficient in differentiating adrenal adenoma from pheochromocytoma. J Magn Reson Imaging2017;
45:1195–1203.
30.
ZhangYChenJLiuS, et al. Assessment of histological differentiation in gastric cancers using whole-volume histogram analysis of apparent diffusion coefficient maps. J Magn Reson Imaging2017;
45:440–449.
